Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Clonus, Computerised tomogram, Dysstasia
Clinical narrative: Central Nervous System- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Sudden intense back pain; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03May2021 as dose 2, single (Lot number: EW0167) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history included: "Migraines" (unspecified if ongoing), notes: Migraines; "Hypothyroid" (unspecified if ongoing); "known allergies: Sulpha Antibiotics" (unspecified if ongoing), notes: Sulpha Antibiotics; "back and neck fusions" (unspecified if ongoing), notes: back and neck fusions. Concomitant medication(s) included: ARMOUR THYROID taken for hypothyroidism; PAROXETINE; B12 [CYANOCOBALAMIN]; D3. Past drug history included: Sudafed, reaction(s): "known allergies: Sudafed", notes: known allergies: Sudafed. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: ER8729), administration date: 05Apr2021, when the patient was 59-year-old, for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: NEUROPATHY PERIPHERAL (caused and prolonged hospitalization, disability, medically significant) with onset 11Jun2021, outcome "not recovered", described as "Central Nervous System- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words"; GAIT DISTURBANCE (caused and prolonged hospitalization, disability), DYSSTASIA (caused and prolonged hospitalization, disability), CLONUS (caused and prolonged hospitalization, disability), TREMOR (caused and prolonged hospitalization, disability), ASTHENIA (caused and prolonged hospitalization, disability), MEMORY IMPAIRMENT (caused and prolonged hospitalization, disability), NERVOUS SYSTEM DISORDER (caused and prolonged hospitalization, disability) all with onset 11Jun2021, outcome "not recovered" and all described as "Central Nervous Sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words"; BACK PAIN (caused and prolonged hospitalization, disability) with onset 11Jun2021, outcome "not recovered", described as "Sudden intense back pain". The patient was hospitalized and prolonged hospitalization for neuropathy peripheral, back pain, gait disturbance, dysstasia, clonus, tremor, asthenia, memory impairment, nervous system disorder (hospitalization duration: 2 day(s)). The events "central nervous system- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words", "sudden intense back pain" and "central nervous sytem- trouble walking, standing, neuropathy in legs, clonus, shaking, weak, memory issues, trouble with recalling words" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Computerised tomogram: Unknown; lyme test: Negative; Negative, notes: MS and other diseases test; Lumbar puncture: Unknown; Magnetic resonance imaging: Unknown; Nerve conduction studies: Unknown; SARS-CoV-2 test: Negative. Therapeutic measures were taken as a result of neuropathy peripheral, back pain, gait disturbance, dysstasia, clonus, tremor, asthenia, memory impairment, nervous system disorder. Patient received treatment with CAT Scans, MRIs, Lumbar Puncture, Nerve Conduction. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient been tested for COVID-19.